Thrivent Financial For Lutherans Amphastar Pharmaceuticals, Inc. Transaction History
Thrivent Financial For Lutherans
- $50.8 Billion
- Q3 2025
A detailed history of Thrivent Financial For Lutherans transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 25,828 shares of AMPH stock, worth $673,077. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,828
Previous 27,036
4.47%
Holding current value
$673,077
Previous $621,000
10.79%
% of portfolio
0.0%
Previous 0.0%
Shares
33 transactions
Others Institutions Holding AMPH
# of Institutions
263Shares Held
33.5MCall Options Held
73.4KPut Options Held
12.6K-
Black Rock Inc. New York, NY5.94MShares$155 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.63MShares$68.6 Million0.0% of portfolio
-
Td Asset Management Inc1.93MShares$50.3 Million0.05% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.76MShares$45.8 Million0.01% of portfolio
-
State Street Corp Boston, MA1.5MShares$39.1 Million0.0% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.28B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...